Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Pradaxa (drug) published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-5 of 5
» View kspr.com items only
    May 15, 2013 |Story| Hartford Courant

  1. Pharmaceutical Firm's Growth Bucks State Trend

    At Boehringer Ingelheim Pharmaceuticals, the second-largest drug company in Connecticut, the local workforce increased by more than 40 percent over the last 10 years, at the same time its employee numbers worldwide grew by 35 percent.
    The Hartford Courant
    At Boehringer Ingelheim Pharmaceuticals, the second-largest drug company in Connecticut, the local workforce increased by more than 40 percent over the last 10 years, at the same time its employee numbers worldwide grew by 35 percent. A company that...

    Tags: Science and Technology, Research, Medical Research, Danbury, Economy, Business and Finance

    2. Apr 29, 2013 |Story| Los Angeles Times

  2. FDA approves a drug to reverse anticoagulation

    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has always raised the specter of dangerously hard-to-stanch bleeding if someone taking it is wounded or bleeds internally from a fall or a car accident.
    Ever since the drug warfarin was discovered to be a highly effective anti-clotting agent as well as a good rat poison in the early 1950s, it has been the frontline weapon in preventing stroke among those with atrial fibrillation. But its growing use has...

    Tags: Dietary Supplements, Pharmaceuticals, Vitamin K, Warfarin (drug), Cardiac Arrhythmia

    3. Apr 24, 2013 |Story| Reuters

  3. Boehringer anti-clotting pill gains blockbuster status

    Reuters
    INGELHEIM, Germany, April 24 (Reuters) - Boehringer Ingelheim said its anti-blood-clotting drug Pradaxa reached blockbuster status in 2012, helping the world's largest unlisted drugmaker to an 11.5 percent rise in sales for last year. Sales of the pill,...

    Tags: Drugs and Medicines, Germany, Johnson & Johnson Inc., Diabetes, Xarelto (drug)

    4. Nov 12, 2012 |Story| Reuters

  4. Cost becomes bigger question in treating heart disease

    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer.
    Reuters
    LOS ANGELES (Reuters) - The cost of treating heart disease has become a key factor in decisions by U.S. cardiologists grappling with the nation's No. 1 killer. Record prices for drugs and devices, reduced reimbursement by insurance plans and the...

    Tags: Science and Technology, Colleges and Universities, National Institutes of Health, Stanford University, Diseases and Illnesses

    5. Jan 10, 2012 |Story| Los Angeles Times
  5. |Story
Original site for Pradaxa (drug) topic gallery.